Masimo Co. (NASDAQ:MASI) Shares Bought by Treasurer of the State of North Carolina

Treasurer of the State of North Carolina increased its stake in Masimo Co. (NASDAQ:MASI) by 2.0% in the fourth quarter, Holdings Channel reports. The firm owned 19,085 shares of the medical equipment provider’s stock after purchasing an additional 370 shares during the period. Treasurer of the State of North Carolina’s holdings in Masimo were worth $3,155,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Lecap Asset Management Ltd. purchased a new stake in Masimo in the fourth quarter valued at approximately $1,607,000. Nisa Investment Advisors LLC lifted its stake in Masimo by 16,740.0% during the 4th quarter. Nisa Investment Advisors LLC now owns 5,052 shares of the medical equipment provider’s stock valued at $835,000 after acquiring an additional 5,022 shares during the period. Trust Point Inc. acquired a new stake in shares of Masimo in the fourth quarter worth $230,000. Barclays PLC raised its holdings in shares of Masimo by 152.6% during the third quarter. Barclays PLC now owns 39,957 shares of the medical equipment provider’s stock worth $5,329,000 after purchasing an additional 24,137 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its position in Masimo by 1,936.9% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 48,764 shares of the medical equipment provider’s stock valued at $8,220,000 after purchasing an additional 46,370 shares during the period. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Wells Fargo & Company increased their price target on Masimo from $193.00 to $205.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. Piper Sandler raised their target price on Masimo from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Raymond James boosted their price target on Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a report on Friday, December 27th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a report on Thursday, April 10th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Masimo presently has a consensus rating of “Moderate Buy” and a consensus price target of $194.80.

Insider Buying and Selling

In other Masimo news, Director Craig B. Reynolds sold 2,053 shares of the firm’s stock in a transaction on Friday, March 14th. The stock was sold at an average price of $166.13, for a total value of $341,064.89. Following the transaction, the director now owns 16,581 shares in the company, valued at approximately $2,754,601.53. This trade represents a 11.02 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Bilal Muhsin sold 30,000 shares of the company’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $167.49, for a total transaction of $5,024,700.00. Following the sale, the chief operating officer now directly owns 24,172 shares of the company’s stock, valued at $4,048,568.28. The trade was a 55.38 % decrease in their position. The disclosure for this sale can be found here. 16.90% of the stock is currently owned by insiders.

Masimo Trading Down 0.2 %

Shares of MASI stock opened at $151.68 on Thursday. Masimo Co. has a 1-year low of $101.61 and a 1-year high of $194.88. The company has a market cap of $8.20 billion, a price-to-earnings ratio of 104.61 and a beta of 1.28. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The stock has a 50 day simple moving average of $169.06 and a 200-day simple moving average of $164.45.

Masimo (NASDAQ:MASI) last posted its quarterly earnings data on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.38. The business had revenue of $600.70 million for the quarter, compared to the consensus estimate of $593.35 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. On average, equities research analysts expect that Masimo Co. will post 4.1 EPS for the current fiscal year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.